Navigation Links
UBC researchers develop new method to study gambling addictions
Date:6/17/2009

UBC researchers have created the world's first animal laboratory experiment to successfully model human gambling. The advance will help scientists develop and test new treatments for gambling addictions, a devastating condition that affects millions worldwide.

In addition to showing that rats can "play the odds," the study finds that gambling decisions can be impaired or improved with drugs that affect brain dopamine and serotonin levels suggesting that these neurotransmitters may moderate gambling behaviour.

"For most individuals, gambling is enjoyable and harmless, but for others, it is as destructive as being addicted to drugs," says Catharine Winstanley, an assistant professor in UBC's Dept. of Psychology, whose study was published today in the Nature journal Neuropsychopharmacology.

"This new model is an important next step because the neurobiological basis of gambling is still poorly understood and few treatment options exist," adds Winstanley, noting that gamblers experience higher rates of divorce, suicide and crime than non-gamblers. "It brings us a step closer to the goal of drug-based treatments for people suffering from gambling disorders."

For the study, rats had a limited amount of time in which to choose between four gambling options which were associated with the delivery of different numbers of sugar pellets. If the animals won the gamble, they received the associated reward. However, if they lost, they experienced a time-out period during which reward could not be earned.

High-risk options offered more potential sugar pellets but also the possibility of more frequent and longer timeouts. Rats learned how to be successful gamblers, selecting the option with the optimum level of risk and reward to maximize their sugar pellet profits.

The study found that rodents treated with drugs that reduced their levels of serotonin levels associated with impulse control in humans dramatically reduced their ability to play the odds. A drug that reduced dopamine levels associated with pleasure in humans improved their ability to optimize profits. The findings are consistent with recent clinical findings in humans, helping to validate the technique as a model for studying human gambling behaviours.

"We hope this will speed up the development of gambling treatments for humans by giving us a working model to explore drugs and therapies," says Winstanley.

In future studies, Winstanley says she will seek to replicate other aspects of human gambling behaviours, including "loss-chasing" when a gambler follows a loss with a high-risk gamble and the "near-miss effect," when a near-win motivates individuals to continue gambling.


'/>"/>

Contact: Basil Waugh
basil.waugh@ubc.ca
604-822-2048
University of British Columbia
Source:Eurekalert  

Related biology news :

1. UCLA cancer researchers develop model that may help identify cancer stem cells
2. Researchers from around the globe coming to K-State June 21 for workshop on Fusarium fungus
3. Duke, Harvard researchers to monitor bonobo reintroduction
4. Rice University researchers ask if biofuels will lead to a drink or drive
5. Aussie and Kiwi researchers make double MS genetic discovery
6. Researchers describe implausible chemistry that produces herbicidal compound
7. Universitat Autonoma de Barcelona researchers first to clone mice in Spain
8. Protein that triggers plant cell division revealed by researchers
9. Researchers create freestanding nanoparticle films without fillers
10. Researchers identify new risk factor gene for rheumatoid arthritis
11. Researchers shed light on trading behavior in animals -- and humans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UBC researchers develop new method to study gambling addictions
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... Fla. , April 11, 2017 ... and secure authentication solutions, today announced that it ... Intelligence Advanced Research Projects Activity (IARPA) to develop ... Thor program. "Innovation has been a ... IARPA,s Thor program will allow us to innovate ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik Family Foundation and ... Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. Established in ... by the New York Academy of Sciences to honor the excellence of outstanding ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
Breaking Biology Technology: